<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39599809</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>30</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Bone Mineral Density, Bone Biomarkers, and Joints in Acute, Post, and Long COVID-19: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1694</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16111694</ELocationID><Abstract><AbstractText>SARS-CoV-2 is highly transmissible and affects the respiratory system. People with COVID-19 are at higher risk of physical and mental health conditions, which could impact bone health. The aim of this review was to explore the effects of COVID-19 on BMD, BTMs, and joints. An electronic search of the PubMed, Web of Science, Scopus, and Ovid Medline databases considered studies published between 1 January 2020 and 1 November 2023. The search was limited to English, original studies in adult humans. The title and abstract of the identified papers were screened, followed by a full-text review using inclusion and exclusion criteria. The data extracted included the study and participant characteristics, BTMs, BMD, and joint abnormalities. The Newcastle-Ottawa scale quality assessment tool was used to assess the risk of bias. Five studies involving 305 out of 495 infected individuals observed a reduced BMD after COVID-19, with the most significant reduction occurring a year later. Both bone resorption and bone formation markers decreased, while regulatory markers showed higher levels in infected patients. COVID-19 may harm bone health by increasing bone regulatory markers and reducing bone formation and absorption, leading to a lower BMD. Elderly, frail, and osteopenic or osteoporotic individuals are at higher risk and should be regularly monitored for bone loss if they have long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alghamdi</LastName><ForeName>Fahad</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3612-9474</Identifier><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX2 4TH, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiologic Technology, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mokbel</LastName><ForeName>Kinan</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3896-2542</Identifier><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX2 4TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meertens</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2120-8877</Identifier><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX2 4TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obotiba</LastName><ForeName>Abasiama Dick</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0002-8818-032X</Identifier><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX2 4TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharbi</LastName><ForeName>Mansour</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>PACS Admin, Radiology Department, King Khalid Hospital in Kharij, Riyadh 11942, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knapp</LastName><ForeName>Karen M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-7360-0926</Identifier><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX2 4TH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strain</LastName><ForeName>William David</ForeName><Initials>WD</Initials><Identifier Source="ORCID">0000-0002-6826-418X</Identifier><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX2 4TH, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="Y">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007596" MajorTopicYN="N">Joints</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001842" MajorTopicYN="N">Bone and Bones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">DXA</Keyword><Keyword MajorTopicYN="N">MSK ultrasound</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">bone biomarker</Keyword><Keyword MajorTopicYN="N">bone mineral density</Keyword><Keyword MajorTopicYN="N">joints</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39599809</ArticleId><ArticleId IdType="doi">10.3390/v16111694</ArticleId><ArticleId IdType="pii">v16111694</ArticleId><ArticleId IdType="pmc">PMC11599111</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  WHO Coronavirus (COVID-19) Dashboard. 2023.  [(accessed on 10 September 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>GOV.UK  Cases in United Kingdom. GOV.UK Coronavirus (COVID-19) in the UK 2023.  [(accessed on 22 October 2023)]; Available online:  https://coronavirus.data.gov.uk/details/cases?areaType=overview&amp;areaName=United%20Kingdom.</Citation></Reference><Reference><Citation>Larsen J.R., Martin M.R., Martin J.D., Kuhn P., Hicks J.B. Modeling the Onset of Symptoms of COVID-19. Front. Public Health. 2020;8:473. doi: 10.3389/fpubh.2020.00473.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00473</ArticleId><ArticleId IdType="pmc">PMC7438535</ArticleId><ArticleId IdType="pubmed">32903584</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan B.N., Yoo H.J. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) J. Neurol. 2021;268:3059&#x2013;3071. doi: 10.1007/s00415-021-10406-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10406-y</ArticleId><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham J.W., Vaduganathan M., Claggett B.L., Jering K.S., Bhatt A.S., Rosenthal N., Solomon S.D. Clinical Outcomes in Young US Adults Hospitalized with COVID-19. JAMA Intern. Med. 2021;181:379&#x2013;381. doi: 10.1001/jamainternmed.2020.5313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.5313</ArticleId><ArticleId IdType="pmc">PMC7489373</ArticleId><ArticleId IdType="pubmed">32902580</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C., Collins L.F., Malani P. Long-term health consequences of COVID-19. JAMA. 2020;324:1723&#x2013;1724. doi: 10.1001/jama.2020.19719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE)  Long-Term Effects of Coronavirus (Long COVID): What Is It? October 2022.  [(accessed on 9 September 2023)].  Available online:  https://cks.nice.org.uk/topics/long-term-effects-of-coronavirus-long-covid/background-information/definition/</Citation></Reference><Reference><Citation>Xu W., Sun N.-N., Gao H.-N., Chen Z.-Y., Yang Y., Ju B., Tang L.-L. Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning. Sci. Rep. 2021;11:2933. doi: 10.1038/s41598-021-82492-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82492-x</ArticleId><ArticleId IdType="pmc">PMC7858607</ArticleId><ArticleId IdType="pubmed">33536460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain M., Khurram Syed S., Fatima M., Shaukat S., Saadullah M., Alqahtani A.M., Alqahtani T., Bin Emran T., Alamri A.H., Barkat M.Q. Acute respiratory distress syndrome and COVID-19: A literature review. J. Inflamm. Res. 2021;14:7225&#x2013;7242. doi: 10.2147/JIR.S334043.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S334043</ArticleId><ArticleId IdType="pmc">PMC8710428</ArticleId><ArticleId IdType="pubmed">34992415</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Peng R., Kang H., Song K., Guo Q., Zhao H., Zhu M., Zhang Y., Guan H., Li F. Global incidence, prevalence, and disability of vertebral fractures: A systematic analysis of the global burden of disease study 2019. Spine J. 2022;22:857&#x2013;868. doi: 10.1016/j.spinee.2021.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2021.12.007</ArticleId><ArticleId IdType="pubmed">34906740</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnell O., Kanis J. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 2006;17:1726&#x2013;1733. doi: 10.1007/s00198-006-0172-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-006-0172-4</ArticleId><ArticleId IdType="pubmed">16983459</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Yu W., Yin X., Cui L., Tang S., Jiang N., Cui L., Zhao N., Lin Q., Chen L. Prevalence of osteoporosis and fracture in China: The China osteoporosis prevalence study. JAMA Netw. Open. 2021;4:e2121106. doi: 10.1001/jamanetworkopen.2021.21106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.21106</ArticleId><ArticleId IdType="pmc">PMC8369359</ArticleId><ArticleId IdType="pubmed">34398202</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton C.E., Ionescu A.A., Shiels K.M., Pettit R.J., Edwards P.H., Stone M.D., Nixon L.S., Evans W.D., Griffiths T.L., Shale D.J. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004;170:1286&#x2013;1293. doi: 10.1164/rccm.200406-754OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200406-754OC</ArticleId><ArticleId IdType="pubmed">15374843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluck O., Colice G. Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest. 2004;125:1859&#x2013;1876. doi: 10.1378/chest.125.5.1859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.125.5.1859</ArticleId><ArticleId IdType="pubmed">15136401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorentzon M., Cummings S.R. Osteoporosis: The evolution of a diagnosis. J. Intern. Med. 2015;277:650&#x2013;661. doi: 10.1111/joim.12369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12369</ArticleId><ArticleId IdType="pubmed">25832448</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue D., Watanabe R., Okazaki R. COPD and osteoporosis: Links, risks, and treatment challenges. Int. J. Chronic Obstr. Pulm. Dis. 2016;11:637&#x2013;648. doi: 10.2147/COPD.S79638.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S79638</ArticleId><ArticleId IdType="pmc">PMC4820217</ArticleId><ArticleId IdType="pubmed">27099481</ArticleId></ArticleIdList></Reference><Reference><Citation>Orford N.R., Bailey M., Bellomo R., Pasco J.A., Cattigan C., Elderkin T., Brennan-Olsen S.L., Cooper D.J., Kotowicz M.A. The association of time and medications with changes in bone mineral density in the 2 years after critical illness. Crit. Care. 2017;21:69. doi: 10.1186/s13054-017-1657-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1657-6</ArticleId><ArticleId IdType="pmc">PMC5361814</ArticleId><ArticleId IdType="pubmed">28327171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapra L., Saini C., Garg B., Gupta R., Verma B., Mishra P.K., Srivastava R.K. Long-term implications of COVID-19 on bone health: Pathophysiology and therapeutics. Inflamm. Res. 2022;71:1025&#x2013;1040. doi: 10.1007/s00011-022-01616-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-022-01616-9</ArticleId><ArticleId IdType="pmc">PMC9330992</ArticleId><ArticleId IdType="pubmed">35900380</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L., Compagnone N., Frara S., Allora A., Doga M., Rovere Querini P., Cremona G., Giustina A. Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors. Endocrine. 2022;77:392&#x2013;400. doi: 10.1007/s12020-022-03096-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03096-7</ArticleId><ArticleId IdType="pubmed">35676466</ArticleId></ArticleIdList></Reference><Reference><Citation>Battisti S., Napoli N., Pedone C., Lombardi M., Leanza G., Tramontana F., Faraj M., Agnoletti V., Verna M., Viola L. Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency. Endocrine. 2021;74:461&#x2013;469. doi: 10.1007/s12020-021-02872-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02872-1</ArticleId><ArticleId IdType="pmc">PMC8444515</ArticleId><ArticleId IdType="pubmed">34529239</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo Y.B., Lim Y.-H., Kim K.-J., Park K.-S., Park Y.-J. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res. Ther. 2019;21:199. doi: 10.1186/s13075-019-1977-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1977-9</ArticleId><ArticleId IdType="pmc">PMC6716891</ArticleId><ArticleId IdType="pubmed">31470887</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipollaro L., Giordano L., Padulo J., Oliva F., Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. BioMed Cent. 2020;15:178. doi: 10.1186/s13018-020-01702-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-020-01702-w</ArticleId><ArticleId IdType="pmc">PMC7232908</ArticleId><ArticleId IdType="pubmed">32423471</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob B., Wiwanitkit V. Arthralgia as an initial presentation of COVID-19: Observation. Rheumatol. Int. 2020;40:823. doi: 10.1007/s00296-020-04561-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04561-0</ArticleId><ArticleId IdType="pmc">PMC7103099</ArticleId><ArticleId IdType="pubmed">32222804</ArticleId></ArticleIdList></Reference><Reference><Citation>Schett G., Manger B., Simon D., Caporali R. COVID-19 revisiting inflammatory pathways of arthritis. Nat. Rev. Rheumatol. 2020;16:465&#x2013;470. doi: 10.1038/s41584-020-0451-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0451-z</ArticleId><ArticleId IdType="pmc">PMC7304381</ArticleId><ArticleId IdType="pubmed">32561873</ArticleId></ArticleIdList></Reference><Reference><Citation>Derksen V.F., Kissel T., Lamers-Karnebeek F.B., van der Bijl A.E., Venhuizen A.C., Huizinga T.W., Toes R.E., Roukens A.H., van der Woude D. Onset of rheumatoid arthritis after COVID-19: Coincidence or connected? Ann. Rheum. Dis. 2021;80:1096&#x2013;1098. doi: 10.1136/annrheumdis-2021-219859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-219859</ArticleId><ArticleId IdType="pubmed">33648960</ArticleId></ArticleIdList></Reference><Reference><Citation>Metyas S., Chen C., Aung T., Ballester A., Cheav S. Rheumatologic manifestations of post SARS-CoV-2 infection: A case series. Curr. Rheumatol. Rev. 2022;18:346&#x2013;351. doi: 10.2174/1573397118666220211155716.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573397118666220211155716</ArticleId><ArticleId IdType="pubmed">35152867</ArticleId></ArticleIdList></Reference><Reference><Citation>Slouma M., Abbes M., Mehmli T., Dhahri R., Metoui L., Gharsallah I., Louzir B. Reactive arthritis occurring after COVID-19 infection: A narrative review. Infection. 2023;51:37&#x2013;45. doi: 10.1007/s15010-022-01858-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01858-z</ArticleId><ArticleId IdType="pmc">PMC9162104</ArticleId><ArticleId IdType="pubmed">35655110</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., G&#xfc;neri F.D., Karde&#x15f; S. Long COVID: Rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin. Rheumatol. 2022;41:289&#x2013;296. doi: 10.1007/s10067-021-05942-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaffi J., Vanni E., Mancarella L., Brusi V., Lisi L., Pignatti F., Naldi S., Assirelli E., Neri S., Reta M. Post-acute COVID-19 joint pain and new onset of rheumatic musculoskeletal diseases: A systematic review. Diagnostics. 2023;13:1850. doi: 10.3390/diagnostics13111850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13111850</ArticleId><ArticleId IdType="pmc">PMC10252492</ArticleId><ArticleId IdType="pubmed">37296705</ArticleId></ArticleIdList></Reference><Reference><Citation>Schardt C., Adams M.B., Owens T., Keitz S., Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med. Inform. Decis. Mak. 2007;7:16. doi: 10.1186/1472-6947-7-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-7-16</ArticleId><ArticleId IdType="pmc">PMC1904193</ArticleId><ArticleId IdType="pubmed">17573961</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A., Altman D.G., Tetzlaff J., Mulrow C., G&#xf8;tzsche P.C., Ioannidis J.P., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol. 2009;62:e1&#x2013;e34. doi: 10.1016/j.jclinepi.2009.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.006</ArticleId><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Shea B., O&#x2019;Connell D., Peterson J., Welch V., Losos M., Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. 2000.  [(accessed on 10 November 2023)].  Available online:  https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Herzog R., &#xc1;lvarez-Pasquin M.J., D&#xed;az C., Del Barrio J.L., Estrada J.M., Gil &#xc1;. Are healthcare workers&#x2019; intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13:154. doi: 10.1186/1471-2458-13-154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-13-154</ArticleId><ArticleId IdType="pmc">PMC3602084</ArticleId><ArticleId IdType="pubmed">23421987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerschan-Schindl K., Dovjak P., Butylina M., Rainer A., Mayr B., R&#xf6;ggla V., Haslacher H., Weber M., Jordakieva G., Pietschmann P. Moderate COVID-19 disease is associated with reduced bone turnover. J. Bone Miner. Res. 2023;38:943&#x2013;950. doi: 10.1002/jbmr.4822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.4822</ArticleId><ArticleId IdType="pubmed">37126438</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmedany S.H., Badr O.I., Abu-Zaid M.H., Tabra S.A.A. Bone mineral density changes in osteoporotic and osteopenic patients after COVID-19 infection. Egypt. Rheumatol. Rehabil. 2022;49:64. doi: 10.1186/s43166-022-00165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43166-022-00165-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkta&#x15f; B., G&#xf6;k&#xe7;ek A., Hoca N., Koyuncu A. COVID-19 illness and treatment decrease bone mineral density of surviving hospitalized patients. Eur. Rev. Med. Pharmacol. Sci. 2022;26:3046&#x2013;3056.</Citation><ArticleIdList><ArticleId IdType="pubmed">35503607</ArticleId></ArticleIdList></Reference><Reference><Citation>Moga T.D., Nistor-Cseppento C.D., Bungau S.G., Tit D.M., Sabau A.M., Behl T., Nechifor A.C., Bungau A.F., Negrut N. The effects of the &#x2018;catabolic crisis&#x2019; on patients&#x2019; prolonged immobility after COVID-19 Infection. Medicina. 2022;58:828. doi: 10.3390/medicina58060828.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58060828</ArticleId><ArticleId IdType="pmc">PMC9231342</ArticleId><ArticleId IdType="pubmed">35744091</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Azzawi I.S., Mohammed N.S., Saad I. The impact of angiotensin converting enzyme-2 (ACE-2) on bone remodeling marker osteoprotegerin (OPG) in post-COVID-19 Iraqi patients. Cureus. 2022;14:e29926. doi: 10.7759/cureus.29926.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.29926</ArticleId><ArticleId IdType="pmc">PMC9633432</ArticleId><ArticleId IdType="pubmed">36348825</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmisano A., Gnasso C., Cereda A., Vignale D., Leone R., Nicoletti V., Barbieri S., Toselli M., Giannini F., Loffi M. Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: A retrospective multicentre study. Eur. Radiol. 2023;33:7756&#x2013;7768. doi: 10.1007/s00330-023-09702-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-023-09702-0</ArticleId><ArticleId IdType="pmc">PMC10173240</ArticleId><ArticleId IdType="pubmed">37166497</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhsh N., Banjar M., Baig M. Correlation of bone density measured on CT chest with the severity of COVID-19 infection: A retrospective study. PLoS ONE. 2023;18:e0286395. doi: 10.1371/journal.pone.0286395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0286395</ArticleId><ArticleId IdType="pmc">PMC10249830</ArticleId><ArticleId IdType="pubmed">37289783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottlors J., Hokamp N.G., Fervers P., Bremm J., Fichter F., Persigehl T., Safarov O., Maintz D., Tritt S., Abdullayev N. Early extrapulmonary prognostic features in chest computed tomography in COVID-19 pneumonia: Bone mineral density is a relevant predictor for the clinical outcome-A multicenter feasibility study. Bone. 2021;144:115790. doi: 10.1016/j.bone.2020.115790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2020.115790</ArticleId><ArticleId IdType="pmc">PMC7720732</ArticleId><ArticleId IdType="pubmed">33301962</ArticleId></ArticleIdList></Reference><Reference><Citation>Subasi M., Duger M., Erol C., Durur-Subasi I. Opportunistic retrospective assessment of HUAC, bone density, SFT and breast density on CT images and relationship with severity of COVID-19. J. Mind Med. Sci. 2023;10:148&#x2013;155. doi: 10.22543/2392-7674.1371.</Citation><ArticleIdList><ArticleId IdType="doi">10.22543/2392-7674.1371</ArticleId></ArticleIdList></Reference><Reference><Citation>do Amaral E Castro A., Yokoo P., Fonseca E.K.U.N., Otoni J.C., Haiek S.L., Shoji H., Chate R.C., Pereira A.Z., Queiroz M.R.G.d., Batista M.C. Prognostic factors of worse outcome for hospitalized COVID-19 patients, with emphasis on chest computed tomography data: A retrospective study. Einstein. 2022;20:eAO6953. doi: 10.31744/einstein_journal/2022AO6953.</Citation><ArticleIdList><ArticleId IdType="doi">10.31744/einstein_journal/2022AO6953</ArticleId><ArticleId IdType="pmc">PMC9126606</ArticleId><ArticleId IdType="pubmed">35649055</ArticleId></ArticleIdList></Reference><Reference><Citation>Emekli E., Bostanc&#x131; Can E.Z. Prognostic Value of Diaphragm Diameter, Muscle Volume, and Bone Mineral Density in Critically Ill COVID-19 Patients. J. Intensive Care Med. 2023;38:847&#x2013;855. doi: 10.1177/08850666231169494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666231169494</ArticleId><ArticleId IdType="pmc">PMC10099913</ArticleId><ArticleId IdType="pubmed">37050868</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Toro R., Palmese F., Feletti F., Zani G., Minguzzi M.T., Maddaloni E., Napoli N., Bedogni G., Domenicali M. Relationship between Muscle Mass, Bone Density and Vascular Calcifications in Elderly People with SARS-CoV-2 Pneumonia. J. Clin. Med. 2023;12:2372. doi: 10.3390/jcm12062372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12062372</ArticleId><ArticleId IdType="pmc">PMC10059976</ArticleId><ArticleId IdType="pubmed">36983372</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahtabasi M., Kilicaslan N., Akin Y., Karaman E., Gezer M., Icen Y.K., Sahiner F. The prognostic value of vertebral bone density on chest CT in hospitalized COVID-19 patients. J. Clin. Densitom. 2021;24:506&#x2013;515. doi: 10.1016/j.jocd.2021.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2021.07.007</ArticleId><ArticleId IdType="pmc">PMC8302819</ArticleId><ArticleId IdType="pubmed">34353732</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrieta F., Martinez-Vaello V., Bengoa N., Rosillo M., de Pablo A., Voguel C., Pintor R., Belanger-Quintana A., Mateo-Lobo R., Candela A. Stress hyperglycemia and osteocalcin in COVID-19 critically ill patients on artificial nutrition. Nutrients. 2021;13:3010. doi: 10.3390/nu13093010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13093010</ArticleId><ArticleId IdType="pmc">PMC8470880</ArticleId><ArticleId IdType="pubmed">34578888</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Wang L., Wang H., Gao Y., Hu X., Li X., Zhang S., Xu Y., Wei W. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: Diagnostic value in organ injuries. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:2447&#x2013;2455. doi: 10.1007/s10096-020-03967-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-03967-9</ArticleId><ArticleId IdType="pmc">PMC7329266</ArticleId><ArticleId IdType="pubmed">32613308</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler D., Ruscitti P., Navarini L., Giacomelli R., Iagnocco A., Hoff P., Burmester G.-R., Ohrndorf S. Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: A case series from three European centres. Clin. Exp. Rheumatol. 2023;41:656&#x2013;666. doi: 10.55563/clinexprheumatol/an1yrh.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/an1yrh</ArticleId><ArticleId IdType="pubmed">35916289</ArticleId></ArticleIdList></Reference><Reference><Citation>Namakin K., Sadeghzadeh S., Tamimi A., Abdolzadeh A., Khanjani Z., Ebrahimi N., Abdolmohammadi G., Golshan A., Fardoost S., Masrouri S. The association between COVID-19 and reactive arthritis: A systematic review of case reports and case series. Curr. Rheumatol. Rev. 2023;19:420&#x2013;438. doi: 10.2174/1573397119666230316091809.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573397119666230316091809</ArticleId><ArticleId IdType="pubmed">36927426</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wu H., Xia S.-L. New-onset arthritis following COVID-19 vaccination: A systematic review of case reports. Vaccines. 2023;11:665. doi: 10.3390/vaccines11030665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030665</ArticleId><ArticleId IdType="pmc">PMC10055862</ArticleId><ArticleId IdType="pubmed">36992249</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandinelli F., Pagano M., Vallecoccia M.S. Post-COVID-19 and Post-COVID-19 Vaccine Arthritis, Polymyalgia Rheumatica and Horton&#x2019;s Arteritis: A Single-Center Assessment of Clinical, Serological, Genetic, and Ultrasonographic Biomarkers. J. Clin. Med. 2023;12:7563. doi: 10.3390/jcm12247563.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12247563</ArticleId><ArticleId IdType="pmc">PMC10743539</ArticleId><ArticleId IdType="pubmed">38137631</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Roongta R., Mondal S., Sinha D., Sinhamahapatra P., Ghosh A., Chattopadhyay A. Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature. Reumatol. Cl&#xed;nica. 2023;19:67&#x2013;73. doi: 10.1016/j.reuma.2022.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC9096625</ArticleId><ArticleId IdType="pubmed">35578636</ArticleId></ArticleIdList></Reference><Reference><Citation>Creecy A., Awosanya O.D., Harris A., Qiao X., Ozanne M., Toepp A.J., Kacena M.A., McCune T. COVID-19 and bone loss: A review of risk factors, mechanisms, and future directions. Curr. Osteoporos. Rep. 2024;22:122&#x2013;134. doi: 10.1007/s11914-023-00842-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11914-023-00842-2</ArticleId><ArticleId IdType="pmc">PMC10912142</ArticleId><ArticleId IdType="pubmed">38221578</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurkovic J. Osteoporosis International. Springer; London, UK: 2021. COVID-19 impact on bone mineral density.</Citation></Reference><Reference><Citation>Awosanya O.D., Dalloul C.E., Blosser R.J., Dadwal U.C., Carozza M., Boschen K., Klemsz M.J., Johnston N.A., Bruzzaniti A., Robinson C.M. Osteoclast-mediated bone loss observed in a COVID-19 mouse model. Bone. 2022;154:116227. doi: 10.1016/j.bone.2021.116227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2021.116227</ArticleId><ArticleId IdType="pmc">PMC8486589</ArticleId><ArticleId IdType="pubmed">34607050</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao W., Lau H.E., Xie H., Poon V.K.-M., Chan C.C.-S., Chu H., Yuan S., Yuen T.T.-T., Chik K.K.-H., Tsang J.O.-L. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat. Commun. 2022;13:2539. doi: 10.1038/s41467-022-30195-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30195-w</ArticleId><ArticleId IdType="pmc">PMC9085785</ArticleId><ArticleId IdType="pubmed">35534483</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz-Junior C.M., Santos A.C., Gon&#xe7;alves M.R., Brito C.B., Barrioni B., Almeida P.J., Gon&#xe7;alves-Pereira M.H., Silva T., Oliveira S.R., Pereira M.M. Acute coronavirus infection triggers a TNF-dependent osteoporotic phenotype in mice. Life Sci. 2023;324:121750. doi: 10.1016/j.lfs.2023.121750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2023.121750</ArticleId><ArticleId IdType="pmc">PMC10152759</ArticleId><ArticleId IdType="pubmed">37142087</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri G.U., Marik P.E., Annane D. Prolonged glucocorticoid treatment in acute respiratory distress syndrome: Evidence supporting effectiveness and safety. Crit. Care Med. 2009;37:1800&#x2013;1803. doi: 10.1097/CCM.0b013e31819d2b43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31819d2b43</ArticleId><ArticleId IdType="pubmed">19373049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S., Zhou Q., Huang L., Shi Q., Zhao S., Wang Z., Li W., Tang Y., Ma Y., Luo X. Effectiveness and safety of glucocorticoids to treat COVID-19: A rapid review and meta-analysis. Ann. Transl. Med. 2020;8:627. doi: 10.21037/atm-20-3307.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-20-3307</ArticleId><ArticleId IdType="pmc">PMC7290628</ArticleId><ArticleId IdType="pubmed">32566564</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J. COVID-19 pandemic and osteoporosis in elderly patients. Aging Dis. 2022;13:960. doi: 10.14336/AD.2021.1201.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.1201</ArticleId><ArticleId IdType="pmc">PMC9286914</ArticleId><ArticleId IdType="pubmed">35855327</ArticleId></ArticleIdList></Reference><Reference><Citation>Celenk C., Celenk P. Bone density measurement using computed tomography. Comput. Tomogr. Clin. Appl. 2012;5:123&#x2013;136.</Citation></Reference><Reference><Citation>Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254&#x2013;1259. doi: 10.1136/bmj.312.7041.1254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.312.7041.1254</ArticleId><ArticleId IdType="pmc">PMC2351094</ArticleId><ArticleId IdType="pubmed">8634613</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp K. Dual energy X-ray absorptiometry: Beyond bone mineral density. Imaging Ther. Pract. 2015;1:5. doi: 10.4172/2379-1764.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2379-1764.1000193</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  Osteoporosis&#x2013;Prevention of Fragility Fractures. July 2021.  [(accessed on 15 March 2022)].  Available online:  https://cks.nice.org.uk/topics/osteoporosis-prevention-of-fragility-fractures/</Citation></Reference><Reference><Citation>Blake G.M., Fogelman I. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad. Med. J. 2007;83:509&#x2013;517. doi: 10.1136/pgmj.2007.057505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2007.057505</ArticleId><ArticleId IdType="pmc">PMC2600106</ArticleId><ArticleId IdType="pubmed">17675543</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasikaran S., Eastell R., Bruy&#xe8;re O., Foldes A., Garnero P., Griesmacher A., McClung M., Morris H.A., Silverman S., Trenti T. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards. Osteoporos. Int. 2011;22:391&#x2013;420. doi: 10.1007/s00198-010-1501-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-010-1501-1</ArticleId><ArticleId IdType="pubmed">21184054</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolagas S.C. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 2000;21:115&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">10782361</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost H.M. Bone Biodynamics. Little; Boston, MA, USA: 1964. Dynamics of bone remodeling; pp. 315&#x2013;334.</Citation></Reference><Reference><Citation>Christenson R.H. Biochemical markers of bone metabolism: An overview. Clin. Biochem. 1997;30:573&#x2013;593. doi: 10.1016/S0009-9120(97)00113-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-9120(97)00113-6</ArticleId><ArticleId IdType="pubmed">9455610</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi J. The correlation of bone mineral density and biochemical markers to fracture risk. Calcif. Tissue Int. 1996;59:S16&#x2013;S19. doi: 10.1007/s002239900170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002239900170</ArticleId><ArticleId IdType="pubmed">8974728</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton III L.J., Crowson C.S., O&#x2019;Fallon W.M., Wahner H.W., Riggs B.L. Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J. Bone Miner. Res. 2003;18:312&#x2013;318. doi: 10.1359/jbmr.2003.18.2.312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2003.18.2.312</ArticleId><ArticleId IdType="pubmed">12568408</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasikaran S., Cooper C., Eastell R., Griesmacher A., Morris H.A., Trenti T., Kanis J.A. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin. Chem. Lab. Med. 2011;49:1271&#x2013;1274. doi: 10.1515/CCLM.2011.602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2011.602</ArticleId><ArticleId IdType="pubmed">21605012</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang N., Liu Y. The role of the immune microenvironment in bone regeneration. Int. J. Med. Sci. 2021;18:3697. doi: 10.7150/ijms.61080.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.61080</ArticleId><ArticleId IdType="pmc">PMC8579305</ArticleId><ArticleId IdType="pubmed">34790042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sponholtz T.R., Zhang X., Fontes J.D., Meigs J.B., Cupples L.A., Kiel D.P., Hannan M.T., McLean R.R. Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and women. Arthritis Care Res. 2014;66:1233&#x2013;1240. doi: 10.1002/acr.22270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22270</ArticleId><ArticleId IdType="pmc">PMC4069198</ArticleId><ArticleId IdType="pubmed">24375982</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamone L., Whiteside T., Friberg D., Epstein R., Kuller L., Cauley J. Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women. Calcif. Tissue Int. 1998;63:466&#x2013;470. doi: 10.1007/s002239900559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002239900559</ArticleId><ArticleId IdType="pubmed">9817939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H.-S., Park Y.-H., Kim S.-K. Relationship between serum inflammatory marker and bone mineral density in healthy adults. J. Bone Metab. 2016;23:27&#x2013;33. doi: 10.11005/jbm.2016.23.1.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.11005/jbm.2016.23.1.27</ArticleId><ArticleId IdType="pmc">PMC4791435</ArticleId><ArticleId IdType="pubmed">26981518</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Lee S., Knoll J., Rauch A., Ostermay S., Luther J., Malkusch N., Lerner U.H., Zaiss M.M., Neven M. Loss of menin in osteoblast lineage affects osteocyte&#x2013;osteoclast crosstalk causing osteoporosis. Cell Death Differ. 2017;24:672&#x2013;682. doi: 10.1038/cdd.2016.165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2016.165</ArticleId><ArticleId IdType="pmc">PMC5384024</ArticleId><ArticleId IdType="pubmed">28106886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Penninger J.M. Angiotensin-converting enzyme 2 in lung diseases. Curr. Opin. Pharmacol. 2006;6:271&#x2013;276. doi: 10.1016/j.coph.2006.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2006.03.001</ArticleId><ArticleId IdType="pmc">PMC7106490</ArticleId><ArticleId IdType="pubmed">16581295</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisz L.G. Physiology and pathophysiology of bone remodeling. Clin. Chem. 1999;45:1353&#x2013;1358.</Citation><ArticleIdList><ArticleId IdType="pubmed">10430818</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X., McDonald J.M. Disorders of bone remodeling. Annu. Rev. Pathol. Mech. Dis. 2011;6:121&#x2013;145. doi: 10.1146/annurev-pathol-011110-130203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-011110-130203</ArticleId><ArticleId IdType="pmc">PMC3571087</ArticleId><ArticleId IdType="pubmed">20936937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi B., Xiong Y., Zhang C., Zhou W., Chen L., Cao F., Chen F., Geng Z., Panayi A.C., Sun Y., et al. SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing. Int. J. Biol. Sci. 2021;17:1277&#x2013;1288. doi: 10.7150/ijbs.56657.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.56657</ArticleId><ArticleId IdType="pmc">PMC8040480</ArticleId><ArticleId IdType="pubmed">33867845</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266&#x2013;281. doi: 10.1056/NEJMra070553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra070553</ArticleId><ArticleId IdType="pubmed">17634462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lips P., Van Schoor N.M. The effect of vitamin D on bone and osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 2011;25:585&#x2013;591. doi: 10.1016/j.beem.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2011.05.002</ArticleId><ArticleId IdType="pubmed">21872800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 2001;22:477&#x2013;501. doi: 10.1210/edrv.22.4.0437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/edrv.22.4.0437</ArticleId><ArticleId IdType="pubmed">11493580</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchuk N.O., van Schoor N.M., Pluijm S.M., Chines A., Lips P. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: Global perspective. J. Bone Miner. Res. 2009;24:693&#x2013;701. doi: 10.1359/jbmr.081209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.081209</ArticleId><ArticleId IdType="pubmed">19049341</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Rosa M., Malaguarnera M., Nicoletti F., Malaguarnera L. Vitamin D3: A helpful immuno-modulator. Immunology. 2011;134:123&#x2013;139. doi: 10.1111/j.1365-2567.2011.03482.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2011.03482.x</ArticleId><ArticleId IdType="pmc">PMC3194221</ArticleId><ArticleId IdType="pubmed">21896008</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiller C.L., Martineau A.R. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7:4240&#x2013;4270. doi: 10.3390/nu7064240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7064240</ArticleId><ArticleId IdType="pmc">PMC4488782</ArticleId><ArticleId IdType="pubmed">26035247</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird E., Rhodes J., Kenny R.A. Vitamin D and inflammation: Potential implications for severity of COVID-19. Ir. Med. J. 2020;113:81.</Citation><ArticleIdList><ArticleId IdType="pubmed">32603576</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle D.D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 2014;21:319&#x2013;329. doi: 10.1016/j.chembiol.2013.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2013.12.016</ArticleId><ArticleId IdType="pmc">PMC3968073</ArticleId><ArticleId IdType="pubmed">24529992</ArticleId></ArticleIdList></Reference><Reference><Citation>Sassi F., Tamone C., D&#x2019;Amelio P. Vitamin D: Nutrient, hormone, and immunomodulator. Nutrients. 2018;10:1656. doi: 10.3390/nu10111656.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10111656</ArticleId><ArticleId IdType="pmc">PMC6266123</ArticleId><ArticleId IdType="pubmed">30400332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui L., Zhu Z., Hawkins S., Cortez-Resendiz A., Bellon A. Vitamin D regulation of the immune system and its implications for COVID-19: A mini review. SAGE Open Med. 2021;9:20503121211014073. doi: 10.1177/20503121211014073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20503121211014073</ArticleId><ArticleId IdType="pmc">PMC8135207</ArticleId><ArticleId IdType="pubmed">34046177</ArticleId></ArticleIdList></Reference><Reference><Citation>Argano C., Mallaci Bocchio R., Natoli G., Scibetta S., Lo Monaco M., Corrao S. Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis. Pharmaceuticals. 2023;16:130. doi: 10.3390/ph16010130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph16010130</ArticleId><ArticleId IdType="pmc">PMC9864223</ArticleId><ArticleId IdType="pubmed">36678627</ArticleId></ArticleIdList></Reference><Reference><Citation>Varikasuvu S.R., Thangappazham B., Vykunta A., Duggina P., Manne M., Raj H., Aloori S. COVID-19 and vitamin D (Co-VIVID study): A systematic review and meta-analysis of randomized controlled trials. Expert Rev. Anti-Infect. Ther. 2022;20:907&#x2013;913. doi: 10.1080/14787210.2022.2035217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2022.2035217</ArticleId><ArticleId IdType="pmc">PMC8862170</ArticleId><ArticleId IdType="pubmed">35086394</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L., Uygur M., Locatelli M., Nannipieri F., Frara S., Giustina A. Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization. Endocrine. 2023;80:669&#x2013;683. doi: 10.1007/s12020-023-03331-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-023-03331-9</ArticleId><ArticleId IdType="pmc">PMC9974397</ArticleId><ArticleId IdType="pubmed">36854858</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet P., Uebelhart D., Vico L., Moro L., Hartmann D., Roth M., Alexandre C. Effects of 1-and 6-month spaceflight on bone mass and biochemistry in two humans. Bone. 1997;20:547&#x2013;551. doi: 10.1016/S8756-3282(97)00052-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S8756-3282(97)00052-5</ArticleId><ArticleId IdType="pubmed">9177869</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto J., Takeda T., Sato Y. Interventions to prevent bone loss in astronauts during space flight. Keio J. Med. 2005;54:55&#x2013;59. doi: 10.2302/kjm.54.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.2302/kjm.54.55</ArticleId><ArticleId IdType="pubmed">16077253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibonga J.D., Spector E.R., Johnston S.L., Tarver W.J. Evaluating bone loss in ISS astronauts. Aerosp. Med. Hum. Perform. 2015;86:A38&#x2013;A44. doi: 10.3357/AMHP.EC06.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3357/AMHP.EC06.2015</ArticleId><ArticleId IdType="pubmed">26630194</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp K.M., Rowlands A.V., Welsman J.R., MacLeod K.M. Prolonged unilateral disuse osteopenia 14 years post external fixator removal: A case history and critical review. Case Rep. Med. 2010;2010:629020. doi: 10.1155/2010/629020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/629020</ArticleId><ArticleId IdType="pmc">PMC2858376</ArticleId><ArticleId IdType="pubmed">20445732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundry M., Hopkins S., Knapp K. A review on bone mineral density loss in total knee replacements leading to increased fracture risk. Clin. Rev. Bone Miner. Metab. 2017;15:162&#x2013;174. doi: 10.1007/s12018-017-9238-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12018-017-9238-4</ArticleId><ArticleId IdType="pmc">PMC5698368</ArticleId><ArticleId IdType="pubmed">29213219</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole K.E., Warburton E.A., Reeve J. Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis. Osteoporos. Int. 2005;16:302&#x2013;305. doi: 10.1007/s00198-004-1682-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-004-1682-6</ArticleId><ArticleId IdType="pubmed">15197547</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins S., Toms A., Brown M., Welsman J., Ukoumunne O., Knapp K. A study investigating short-and medium-term effects on function, bone mineral density and lean tissue mass post-total knee replacement in a Caucasian female post-menopausal population: Implications for hip fracture risk. Osteoporos. Int. 2016;27:2567&#x2013;2576. doi: 10.1007/s00198-016-3546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-016-3546-2</ArticleId><ArticleId IdType="pubmed">26919995</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., Morgan M.D. The systemic nature of chronic lung disease. Clin. Chest Med. 2014;35:283&#x2013;293. doi: 10.1016/j.ccm.2014.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2014.02.009</ArticleId><ArticleId IdType="pubmed">24874124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T., Otsuka Y., Aoki H., Goto Y., Kawaguchi Y., Waguri-Nagaya Y., Miyazawa K., Goto S., Aoyama M. The inducible nitric oxide synthase pathway promotes osteoclastogenesis under hypoxic culture conditions. Am. J. Pathol. 2021;191:2072&#x2013;2079. doi: 10.1016/j.ajpath.2021.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.08.014</ArticleId><ArticleId IdType="pubmed">34560064</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouqui P., Amrane S., Million M., Cortaredona S., Parola P., Lagier J.-C., Raoult D. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int. J. Infect. Dis. 2021;102:233&#x2013;238. doi: 10.1016/j.ijid.2020.10.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.067</ArticleId><ArticleId IdType="pmc">PMC7604151</ArticleId><ArticleId IdType="pubmed">33130200</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwaan H.C., Lindholm P.F. The central role of fibrinolytic response in COVID-19&#x2014;A hematologist&#x2019;s perspective. Int. J. Mol. Sci. 2021;22:1283. doi: 10.3390/ijms22031283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031283</ArticleId><ArticleId IdType="pmc">PMC7919196</ArticleId><ArticleId IdType="pubmed">33525440</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:1&#x2013;18. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitar A.N., Sulaiman S.A.S., Ali I.A.B.H., Khan A.H. Prevalence, risk assessment, and predictors of osteoporosis among chronic obstructive pulmonary disease patients. J. Adv. Pharm. Technol. Res. 2021;12:395. doi: 10.4103/japtr.japtr_98_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/japtr.japtr_98_21</ArticleId><ArticleId IdType="pmc">PMC8588927</ArticleId><ArticleId IdType="pubmed">34820316</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelsson K.F., Litsne H., Lorentzon M. Fractures and fall injuries after hospitalization for seasonal influenza&#x2014;A national retrospective cohort study. Osteoporos. Int. 2022;33:47&#x2013;56. doi: 10.1007/s00198-021-06068-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-021-06068-1</ArticleId><ArticleId IdType="pmc">PMC8390060</ArticleId><ArticleId IdType="pubmed">34436639</ArticleId></ArticleIdList></Reference><Reference><Citation>Glesby M.J. Bone disorders in human immunodeficiency virus infection. Clin. Infect. Dis. 2003;37:S91&#x2013;S95. doi: 10.1086/375884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/375884</ArticleId><ArticleId IdType="pubmed">12942380</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-Y., Fang W.-H., Wang C.-C., Kao T.-W., Chang Y.-W., Yang H.-F., Wu C.-J., Sun Y.-S., Chen W.-L. Crosssectional assessment of bone mass density in adults with hepatitis B virus and hepatitis C virus infection. Sci. Rep. 2019;9:5069. doi: 10.1038/s41598-019-41674-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41674-4</ArticleId><ArticleId IdType="pmc">PMC6433944</ArticleId><ArticleId IdType="pubmed">30911051</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Li J., Liu H., Han N., Ju J., Kou Y., Chen L., Jiang M., Pan F., Zheng Y., et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: A 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8. doi: 10.1038/s41413-020-0084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau E., Chan F., Hui D., Wu A., Leung P. Reduced bone mineral density in male severe acute respiratory syndrome (SARS) patients in Hong Kong. Bone. 2005;37:420&#x2013;424. doi: 10.1016/j.bone.2005.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2005.04.018</ArticleId><ArticleId IdType="pmc">PMC7103402</ArticleId><ArticleId IdType="pubmed">15993669</ArticleId></ArticleIdList></Reference><Reference><Citation>Selmi C., Gershwin M.E. Diagnosis and classification of reactive arthritis. Autoimmun. Rev. 2014;13:546&#x2013;549. doi: 10.1016/j.autrev.2014.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2014.01.005</ArticleId><ArticleId IdType="pubmed">24418301</ArticleId></ArticleIdList></Reference><Reference><Citation>Siva C., Velazquez C., Mody A., Brasington R. Diagnosing acute monoarthritis in adults: A practical approach for the family physician. Am. Fam. Physician. 2003;68:83&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">12887114</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi S., Borrelli R., Bianchi S., Fusaro E. Viral arthritis and COVID-19. Lancet Rheumatol. 2020;2:e655&#x2013;e657. doi: 10.1016/S2665-9913(20)30348-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30348-9</ArticleId><ArticleId IdType="pmc">PMC7535796</ArticleId><ArticleId IdType="pubmed">33043303</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimukhamedov C., Barskova T., Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3:e324&#x2013;e325. doi: 10.1016/S2665-9913(21)00067-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00067-9</ArticleId><ArticleId IdType="pmc">PMC7963449</ArticleId><ArticleId IdType="pubmed">33748780</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukarram M.S., Ishaq Ghauri M., Sethar S., Afsar N., Riaz A., Ishaq K. COVID-19: An emerging culprit of inflammatory arthritis. Case Rep. Rheumatol. 2021;2021:6610340. doi: 10.1155/2021/6610340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6610340</ArticleId><ArticleId IdType="pmc">PMC8077721</ArticleId><ArticleId IdType="pubmed">33986966</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassi M., Giorgi V., Nebuloni M., Zerbi P., Gismondo M.R., Salaffi F., Sarzi-Puttini P., Rimoldi S.G., Manzotti A. SARS-CoV-2 in the knee joint: A cadaver study. Clin. Exp. Rheumatol. 2021;40:608&#x2013;612. doi: 10.55563/clinexprheumatol/t1m4y2.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/t1m4y2</ArticleId><ArticleId IdType="pubmed">34665699</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew I.Y., Mak T.M., Cui L., Vasoo S., Lim X.R. A Case of Reactive Arthritis Secondary to Coronavirus Disease 2019 Infection. JCR J. Clin. Rheumatol. 2020;26:233. doi: 10.1097/RHU.0000000000001560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000001560</ArticleId><ArticleId IdType="pmc">PMC7437408</ArticleId><ArticleId IdType="pubmed">32694352</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokogawa N., Minematsu N., Katano H., Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann. Rheum. Dis. 2021;80:e101. doi: 10.1136/annrheumdis-2020-218281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218281</ArticleId><ArticleId IdType="pubmed">32591356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K., Kishimoto M., Shimasaki T., Uchida H., Kurai D., Deshpande G.A., Komagata Y., Kaname S. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350. doi: 10.1136/rmdopen-2020-001350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2020-001350</ArticleId><ArticleId IdType="pmc">PMC7722270</ArticleId><ArticleId IdType="pubmed">32763956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaeley G.S., Bakewell C., Deodhar A. The importance of ultrasound in identifying and differentiating patients with early inflammatory arthritis: A narrative review. Arthritis Res. Ther. 2020;22:1. doi: 10.1186/s13075-019-2050-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-2050-4</ArticleId><ArticleId IdType="pmc">PMC6939339</ArticleId><ArticleId IdType="pubmed">31898524</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippucci E., Cipolletta E., Mashadi Mirza R., Carotti M., Giovagnoni A., Salaffi F., Tardella M., Di Matteo A., Di Carlo M. Ultrasound imaging in rheumatoid arthritis. La Radiol. Medica. 2019;124:1087&#x2013;1100. doi: 10.1007/s11547-019-01002-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11547-019-01002-2</ArticleId><ArticleId IdType="pubmed">30852792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazarian L.N. The top 10 reasons musculoskeletal sonography is an important complementary or alternative technique to MRI. Am. J. Roentgenol. 2008;190:1621. doi: 10.2214/AJR.07.3385.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.07.3385</ArticleId><ArticleId IdType="pubmed">18492916</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight K., Fordham R., Crabtree N., Knapp K. Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019&#x2013;2023. Osteoporos. Int. 2024;35:1451&#x2013;1460. doi: 10.1007/s00198-024-07120-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-024-07120-6</ArticleId><ArticleId IdType="pubmed">38795142</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi F., Owen R., Ashton R., Obotiba A., Meertens R., Hyde E., Faghy M., Knapp K., Rogers P., Strain W. Post-acute COVID syndrome (long COVID): What should radiographers know and the potential impact for imaging services. Radiography. 2022;28:S93&#x2013;S99. doi: 10.1016/j.radi.2022.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radi.2022.08.009</ArticleId><ArticleId IdType="pmc">PMC9468096</ArticleId><ArticleId IdType="pubmed">36109264</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK: 30 March 2023.  [(accessed on 1 November 2023)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023.</Citation></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y.-J., Liu S.-H., Manachevakul S., Lee T.-A., Kuo C.-T., Bello D. Biomarkers in long COVID-19: A systematic review. Front. Med. 2023;10:1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E., Yang C., Shannon C.P., Assadian S., He D., Tebbutt S.J. Cellular and molecular biomarkers of long COVID: A scoping review. Ebiomedicine. 2023;91:104552. doi: 10.1016/j.ebiom.2023.104552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L., Frara S., Nannipieri F., Cotellessa A., Locatelli M., Rovere Querini P., Giustina A. Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors. J. Clin. Endocrinol. Metab. 2023;108:e1106&#x2013;e1116. doi: 10.1210/clinem/dgad207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad207</ArticleId><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="pubmed">37051747</ArticleId></ArticleIdList></Reference><Reference><Citation>An Open-Label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID. (ERASE-LC)  [(accessed on 2 September 2024)];2024  Available online:  https://clinicaltrials.gov/study/NCT05911906.</Citation></Reference><Reference><Citation>Yang W., Zilov A., Soewondo P., Bech O.M., Sekkal F., Home P.D. Observational studies: Going beyond the boundaries of randomized controlled trials. Diabetes Res. Clin. Pract. 2010;88:S3&#x2013;S9. doi: 10.1016/S0168-8227(10)70002-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-8227(10)70002-4</ArticleId><ArticleId IdType="pubmed">20466165</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>